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 Lead poisoning usually occurs in occupational situations, however, there are 
sometimes non-occupational toxicities and opium-related lead poisoning has been reported 
recently. Neuropathy due to lead poisoning can also occur. 
 In this study, a 43 year old man with a history of oral opium use with the complaint 
of progressive muscle weakness was reported. Muscle forces in the upper and lower limbs were 
0/5 and 1/5, respectively. Serum lead level was 88.8 μg/dl. Electrodiagnostic studies were 
indicative of subacute moderate to severe axonal motor polyneuropathy. Following the 
treatment, the muscle force was improved and lead level was decreased. 
 Motor neuropathy due to lead poisoning is a rare but possible complication. Due to 
the increased incidence of opium related lead toxicity in Ardabil, Iran, we recommend to 
consider lead poisoning as one of the possible differential diagnosis of peripheral neuropathy to 
initiate early and proper treatment. 
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Lead poisoning is well recognized worldwide 
among adults and children. It can present 
with a variety of presentations including 
abdominal pain, constipation, irritability, and 
anemia. Fatigue, myalgias, arthralgias, renal 
failure, and neurologic deficits may also be 
seen.1-3 Both the central nervous system and 
the peripheral nervous system become 
affected in lead exposure. Peripheral 
neuropathy may cause reduced motor 
activity causing muscular weakness, 
especially of the exterior muscles, fatigue and 
lack of muscular coordination.1 
It is reported that lead is available in 
opioids used in Iran.4 There are various case 
reports and case series regarding lead 
poisoning due to opium use.5-7 
In the present study, an oral opium addict 
man patient with the complaint of abdominal 
pain and progressive quadreparesis has  
been reported. 
 
A 43-year old man addicted to oral opium 
referred to our emergency department, Imam 
Khomeini Hospital, Ardabil, Iran, with the 
complaint of a progressive muscle weakness of 
upper and lower limbs since the last 7 days. 
The patient had a history of a recurrent 
abdominal pain during the last month before 
visiting our hospital. He had no past medical 
history. He was heavy smoker (15 boxes a year) 
and used oral opium during the last 8 years.  
The presenting symptoms were muscle 
weakness, muscle pain, fatigue, 
undocumented weight loss, palpitation, 
constipation, nausea and insomnia. At 
presentation, the patient was agitated and 
had delirium. Neurologic evaluation showed 
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decreased muscle forces (0/5 and 1/5 in 
upper and lower limbs, respectively) with 
absent deep tendon reflexes (DTR). Other 
evaluations were normal. Laboratory 
findings showed mild normochromic anemia, 
with normal sodium, potassium, urea and 
creatinine, calcium and phosphorus and 
normal liver function tests. The patient had 
an erythrocyte sedimentation rate (ESR) of  
60 and 1+ C-reactive protein (CRP). 
Peripheral blood sampling did not show any 
basophilic stippling. During the period that 
the patient presented to our hospital, there 
was an increased incidence of lead poisoning 
among oral opium addicts in the region 
under study. Serum lead level was 88.8 μg/dl 
which was indicative of lead poisoning.  
Electromyography (EMG) and nerve 
conduction study (NCS) were performed 
which showed decreased compound muscle 
action potential (CMAP) amplitude, normal 
sensory nerve action potential (SNAP), 
normal F wave and H reflex. There was 
fibrillation, positive sharp waves (PSW) and 
polyphasic motor unit action potential 
(MUAP) in some muscles. Results were 
indicative of subacute moderate to severe 
axonal motor polyneuropathy. Given the 
involvement of upper limb more than lower 
limb, EMG-NCS findings and increased 
serum lead level, neuropathy due to lead 
poisoning was considered as the diagnosis.  
The patient was treated with D-Penicillamine 
250 mg QID, gluconate calcium IV QID, 
Vitamin B1 300, B6 and clonidine daily. In 
order to prevent opiate withdrawal signs and 
symptoms, 5 mg methadone three times a 
day was administered.    
Six days after treatment, the proximal 
muscle force in upper and lower limbs 
improved to 2/5 and 4/5, respectively. DTRs 
were changed from absent to hypoactive. 
After 25 days, the muscle force was 5/5 in 
both upper and lower limbs with normal 
DTRs. The patient was discharged with full 
recovery of muscle force and DTRs.  
D-Penicillamine was ordered to be taken at 
home three times a day for two weeks. 
The patient was followed for 6 months 
with no report of complications. Serum lead 
level was 9 μg/dl at the last follow-up.  
A written informed consent was received 
from the patient for publishing his 
information and images. 
 
Peripheral neuropathy refers to disorders of 
the peripheral nervous system. These 
disorders have numerous causes and diverse 
presentations; various systemic diseases, 
toxic exposures, medications, infections, and 
hereditary disorders can cause peripheral 
neuropathy. Metabolic disorders like 
diabetes, hypothyroidism, and nutritional 
deficiencies are the most common and 
treatable forms. Complete blood count, 
evaluation of electrolytes and metabolic 
profile, ESR and CRP, thyroid-stimulating 
hormone (TSH), blood sugar and vitamin B12 
levels are necessary to evaluate a patient with 
peripheral neuropathy.8 
It has been shown that adulteration of lead 
opioids could cause severe lead toxicities.9 In 
the last few months, there was increased rate 
of acute and persistent abdominal pain 
among addicts in the region under study 
which increased the possibility of lead 
poisoning. Therefore, lead levels were 
evaluated among all patients with a history 
of oral opium addiction with possible 
symptoms of lead poisoning.  
The peripheral nervous system is a major 
target organ in lead intoxication. It is 
important to diagnose lead neuropathy, as it 
is potentially reversible, hence other systemic 
complications can be prevented with early 
detection and treatment.1,10 Most cases of lead 
neuropathies are reported among patients 
with industrial exposure,10 however, there is 
only two previous reports regarding 
quadriparesis and neuropathy due to lead 
poisoning among the oral opium users.7,11  
In both cases above, the blood lead level 
was > 200 μg/dl,7,11 however, this rate was 
88.8 μg/dl for the patient in the present 
study. Although there is a generally weak 
relationship between the development of 
lead neuropathy and blood lead levels, 
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however, neurologic symptoms usually occur 
in higher lead levels.10 EMG-NCS are 
performed for the evaluation of peripheral 
neuropathy, especially if the diagnosis 
remains unclear.8 EMG-NCS in the present 
study and two other studies7,11 were 
indicative of motor neuron disease.  
With the termination of the source of 
exposure and proper treatment, these patients 
usually fully recover,10 as seen in the patient of 
the present study and two other case reports.7,11 
 
Motor neuropathy due to lead poisoning is 
a rare but possible complication. Due to the 
increased incidence of opium related lead 
toxicity in the region under study, we 
recommend to consider lead poisoning  
as a possible differential diagnosis of  
peripheral neuropathy to initiate early and 
proper treatment. 
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